PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.\', \'China National Institute for Food and Drug Control, Beijing, China.\', \'Sheyang County Center for Disease Control and Prevention, Yancheng, China.\', \'Jiangdu District Center for Disease Control and Prevention, Yangzhou, China.\', \'Taizhou Center for Disease Control and Prevention, Taizhou, China.\', \'Jiangsu Taizhou People\'s Hospital, Taizhou, China.\', \'Shanghai Canming Medical Technology Co., Ltd, Shanghai, China.\', \'NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. jszfc@vip.sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41392-021-00692-3
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 34267185
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34267185>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34267185>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all